Technology-enhanced AcceleRation of Germline Evaluation for Therapy (TARGET): A randomized controlled trial of a pretest patient-driven webtool vs. genetic counseling for prostate cancer germline testing is a research paper published in Contemporary Clinical Trials (2022). On theSindex it has a DataRank of 0.673. It has been cited 13 times, with 13 citing works in its 1-hop citation network.
Scored on demand from live citation data
Linked data & code
Repositories this paper deposited data in (declared in PubMed).
DataRank reads this dataset's downstream impact straight off the citation graph — no black box, no proprietary weighting. How is this computed?
FAIR checklist signals are shown for context only and do not affect DataRank scoring.
We only score data papers we can read in full — never from an abstract alone.
Base Score Contribution
0.396
From this paper's citation signal
Citation Network Contribution
0.277
From 5 citing papers with measurable signal
Ranked by each citer's contribution to N(p) — log1p(Cq) divided by its reference count — out of 13 citers.
National Institutes of Health
Grant: CA097186
National Institutes of Health
Grant: P30 CA015704
National Institutes of Health
Grant: W81XWH-17-2-0043
Prostate Cancer Foundation
Grant: 19CHAL05
FWCI
1.86
Citation Percentile
0.9%
Citation Trend
Fields of Study
MeSH Terms
Keywords